2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureTheresa A. McDonagh, Heinz Drexel, Marco Metra et al.|European Heart Journal|2021Cited by 13.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J.V. McMurray, Anna-Maria Langkilde, Scott D. Solomon et al.|New England Journal of Medicine|2019Cited by 6.8k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R. Lyon, Julia Grapsa, Teresa López‐Fernández et al.|European Heart Journal|2022Cited by 2.7k
2023 ESC Guidelines for the management of cardiomyopathiesElena Arbelo, Ulf Landmesser, Alexandros Protonotarios et al.|European Heart Journal|2023Cited by 2.3k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureTheresa A. McDonagh, Robert J. Mentz, Gloria Färber et al.|European Heart Journal|2023Cited by 2.2k